- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 176
Zeus Living settles into $55m series B
Airbnb and Comcast both supplied a share of the funding, which the temporary accommodation provider raised at a $205m post-money valuation.
Dec 11, 2019SoftBank buys into Style Theory’s $15m series B
Fashion hire service Style Theory collected the cash from existing investor SoftBank Ventures Asia, Paradise Group and Alpha JWC Ventures.
Dec 9, 2019Group 42 oils HeyGears with $60m
The 3D printing technology provider received $60m from Group 42 in the form of a series B1 investment that marks the corporate's third in a Chinese company this year.
Dec 9, 2019Anaconda consumes $22m
Existing backer Banco Sabadell Venture Capital contributed to a round that will help the stroke surgery device developer fund clinical studies.
Dec 9, 2019Hummingbird feeds on $19m
Kooksoondang Brewery took part in a series B round for oncology antibody developer Hummingbird Bioscience as it prepares to move its lead assets into the clinic.
Dec 9, 2019Infinitum Electric grabs Chevron for series B
Chevron Technology Ventures supplied part of the $12.5m in series B funding secured by electric motor technology developer Infinitum Electric.
Dec 6, 2019Flow floats to $37m series B
Fung Capital-backed cross-border services business Flow won the backing of American Express Ventures in a round that will fund platform development and hiring.
Dec 6, 2019ImCheck imports $53m in series B cash
Pfizer Ventures led the immuno-oncology drug developer's latest round, which was spun out of Institut Paoli-Calmettes with the help of Satt Sud-Est and Inserm Transfert.
Dec 5, 2019Carmakers pull into May Mobility’s $50m series B
Autonomous bus fleet operator May Mobility secured the return of Toyota AI Ventures and BMW i Ventures to bring its overall funding to $84m.
Dec 5, 2019ImCheck imports $53m in series B cash
Pfizer Ventures led the immuno-oncology drug developer's latest round, which included existing backer Boehringer Ingelheim Venture Fund.
Dec 5, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


